AI-powered skin cancer detection study
Part of Cancer, Skin clinical trials.
This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a skin spot that a doctor thinks could be cancer.
- You must be able to understand and sign a consent form.
- You must be able to have clear, good-quality photos taken of your skin spot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial-intelligence smartphone app that helps spot possible skin cancer by looking at skin spots (lesions). You may benefit by getting guidance on whether your new or changing mole needs closer attention.
This study uses artificial intelligence to help detect melanoma (a type of skin cancer) and predict risk in children, teens, and young adults. Researchers want to see if AI can spot melanoma early and assess risk better.
This study tests whether an artificial intelligence (AI) system can detect melanoma better by looking at 3D images of your skin. It may help find skin cancers earlier, especially if you have many moles.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
Hear when a new Skin Cancer Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.